NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-1.62%
2024-27.02%
202340.80%
202225.59%
202189.08%
202035.74%
201960.79%
201829.34%
20170.00%
2016-100.00%